Table 3.
Prognostic factors for overall survival
| Prognostic factors | ||||
|---|---|---|---|---|
| Resected patients | Unresected patients | |||
| UVA | MVA | UVA | MVA | |
| Sex | 0.091 | n.s. | 0.376 | n.s. |
| Age at diagnosis | 0.974 | n.s. | 0.660 | n.s. |
| Tumor location | 0.287 | n.s. | 0.846 | n.s. |
| T | 0.269 | n.s. | 0.992 | n.s. |
| N | 0.226 | n.s. | 0.162 | n.s. |
| Involvement of either duodenum, spleen or adrenal glands | 0.046 | n.s. | 0.778 | n.s. |
| Histologic type | 0.127 | n.s. | 0.634 | n.s. |
| Grading | 0.051 | n.s. | 0.300 | n.s. |
| UICC stage | 0.088 | n.s. | 0.634 | n.s. |
| Karnofsky performance score | 0.629 | n.s. | 0.737 | n.s. |
| Local progression during induction chemotherapy | 0.726 | n.s. | 0.014 | 0.023 |
UVA univariate analysis, MVA multivariate analysis, n.s. not significant